Efficacy and safety of trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastric cancer (mGC) with or without prior gastrectomy: Results from a phase III study (TAGS).

被引：1
|
作者：
Ilson, David H.
Prokharau, Aliaksandr
Arkenau, Hendrik-Tobias
Ghidini, Michele
Fujitani, Kazumasa
Van Cutsem, Eric
Thuss-Patience, Peter C.
Beretta, Giordano D.
Mansoor, Wasat
Zhavrid, Edvard
Alsina, Maria
George, Ben
Catenacci, Daniel V. T.
Winkler, Robert E.
Makris, Lukas
Doi, Toshihiko
Shitara, Kohei
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Minsk City Clin Oncol Dispensary, Minsk, BELARUS
[3] Sarah Cannon Res Inst, London, England
[4] UCL, London, England
[5] Azienda Osped Cremona, Cremona, Italy
[6] Osaka Gen Med Ctr, Osaka, Japan
[7] Univ Hosp, Leuven, Belgium
[8] Katholieke Univ Leuven, Leuven, Belgium
[9] Charite Univ Med Berlin, Berlin, Germany
[10] Humanitas Gavazzeni, Bergamo, Italy
[11] Christie NHS Fdn Trust Hosp, Manchester, Lancs, England
[12] Alexandrov Natl Canc Ctr Belarus, Minsk, BELARUS
[13] Vall dHebron Univ Hosp, Barcelona, Spain
[14] Vall dHebron Inst Oncol, Barcelona, Spain
[15] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[16] Univ Chicago, Med Ctr & Biol Sci, Chicago, IL 60637 USA
[17] Taiho Oncol Inc, Princeton, NJ USA
[18] Stathmi Inc, New Hope, PA USA
[19] Hosp East, Natl Canc Ctr, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Randomized phase III study of bi-weekly trifluridine/tipiracil (FTD/TPI) plus bevacizumab (BEV) vs. FTD/TPI for chemorefractory metastatic colorectal cancer (mCRC): ROBiTS/JCOG2014
    Yamazaki, K.
    Satake, H.
    Takashima, A.
    Mizusawa, J.
    Kataoka, T.
    Fukuda, H.
    Ishizuka, Y.
    Suwa, Y.
    Numata, K.
    Shibata, N.
    Asayama, M.
    Yokota, M.
    Tsushima, T.
    Ohta, T.
    Yamaguchi, T.
    Hamaguchi, T.
    Kanemitsu, Y.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S738 - S738
  • [32] Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy Subgroup Analyses of a Randomized Clinical Trial
    Ilson, David H.
    Tabernero, Josep
    Prokharau, Aliaksandr
    Arkenau, Hendrik-Tobias
    Ghidini, Michele
    Fujitani, Kazumasa
    Van Cutsem, Eric
    Thuss-Patience, Peter
    Beretta, Giordano D.
    Mansoor, Wasat
    Zhavrid, Edvard
    Alsina, Maria
    George, Ben
    Catenacci, Daniel
    McGuigan, Sandra
    Makris, Lukas
    Doi, Toshihiko
    Shitara, Kohei
    JAMA ONCOLOGY, 2020, 6 (01)
  • [33] TAGS: A phase III, randomised, double-blind study of trifluridine/tipiracil (TAS-102) versus placebo in patients with refractory metastatic gastric cancer
    Arkenau, H-T.
    Tabernero, J.
    Shitara, K.
    Dvorkin, M.
    Mansoor, W.
    Prokharau, A.
    Alsina, M.
    Ghidini, M.
    Faustino, C.
    Gorbunova, V.
    Zhavrid, E. A.
    Nishikawa, K.
    Hosokawa, A.
    Ganea, D.
    Yalcin, S.
    Beretta, G. D.
    Winkler, R. E.
    Makris, L.
    Doi, T.
    Ilson, D. H.
    ANNALS OF ONCOLOGY, 2018, 29
  • [34] Efficacy and safety of Trifluridin/Tipiracil (FTD/TPI) (Lonsurf®) in patients with metastatic colorectal cancer (CRC) in clinical-routine use
    Cao, J.
    Wiesweg, M.
    Fuchs, M.
    Stein, A.
    Karthaus, M.
    Lettmaier, S.
    Kretzschmar, A.
    Draube, A.
    Ettrich, T.
    Ruessel, J.
    Mueller, C.
    Rafiyan, M. -R
    Borchert, K.
    Schuler, M.
    Kasper, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 289 - 289
  • [35] Trifluridine/tipiracil (FTD/TPI) in extensively pre-treated metastatic colorectal cancer (mCRC) patients: Evaluation of prognostic subgroups of the TALLISUR study
    Karthaus, Meinolf
    Weiss, Lena
    Riera-Knorrenschild, Jorge
    Kretzschmar, Albrecht
    Welslau, Manfred
    Vehling-Kaiser, Ursula
    Pelz, Henning
    Ettrich, Thomas Jens
    Held, Swantje
    Kehrmann, Linde
    Hess, Juergen
    Reislaender, Timo
    Heinemann, Volker
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] Impact of colorectal liver metastases (CRLM) in patients with metastatic colorectal cancer (mCRC) receiving trifluridine/tipiracil (FTD/TPI) with or without bevacizumab (BEV) in the phase 3 SUNLIGHT trial
    Tabernero, Josep
    Prager, Gerald W.
    Taieb, Julien
    Calleja, Elizabeth Martine
    Liu, Mei
    Amellal, Nadia
    Fakih, Marwan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] Phase I/II study of panitumumab (PANI) combined with trifluridine/tipiracil (FTD/TPI) in patients (pts) with previously treated RAS wild-type (wt) metastatic colorectal cancer (mCRC): Final results of APOLLON study.
    Komatsu, Yoshito
    Kato, Takeshi
    Kagawa, Yoshinori
    Yoshino, Takayuki
    Kuboki, Yasutoshi
    Gamoh, Makio
    Yasui, Hirofumi
    Yamazaki, Kentaro
    Satake, Hironaga
    Goto, Masahiro
    Tanioka, Hiroaki
    Oki, Eiji
    Kotaka, Masahito
    Makiyama, Akitaka
    Denda, Tadamichi
    Soeda, Junpei
    Shibuya, Kazunori
    Iwata, Masaru
    Oba, Koji
    Yamaguchi, Kensei
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [38] Trifluridine-tipiracil (FTD/TPI) plus bevacizumab (BV) in patients (pts) with pretreated metastatic colorectal cancer (mCRC): A real-life Italian multicenter experience
    Trovato, G.
    Carullo, M.
    Zoratto, F.
    Tamberi, S.
    Bergamo, F.
    Basso, M.
    Calegari, M. A.
    Puccini, A.
    Pastorino, A.
    Schirripa, M.
    Lucchetti, J.
    Arrivi, G.
    Morelli, C.
    Cerma, K.
    Troiani, T.
    Morano, F.
    Cremolini, C.
    Martinelli, E.
    Tortora, G.
    Salvatore, L.
    ANNALS OF ONCOLOGY, 2024, 35 : S45 - S45
  • [39] First report of the randomized phase III study of bi-weekly trifluridine/tipiracil (FTD/TPI) plus bevacizumab (BEV) vs. FTD/TPI monotherapy for chemorefractory metastatic colorectal cancer (mCRC): JCOG2014 (ROBiTS).
    Satake, Hironaga
    Yamazaki, Kentaro
    Suwa, Yusuke
    Tsushima, Takahiro
    Ishizuka, Yasunobu
    Boku, Shogen
    Takashima, Atsuo
    Yamaguchi, Toshifumi
    Asayama, Masako
    Yokota, Mitsuru
    Numata, Koji
    Ohta, Takashi
    Yasui, Hisateru
    Kito, Yosuke
    Takii, Yasumasa
    Kitabayashi, Ryo
    Sano, Yusuke
    Fukuda, Haruhiko
    Hamaguchi, Tetsuya
    Kanemitsu, Yukihide
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 118 - 118
  • [40] Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS
    Tabernero, Josep
    Alsina, Maria
    Shitara, Kohei
    Doi, Toshihiko
    Dvorkin, Mikhail
    Mansoor, Wasat
    Arkenau, Hendrik-Tobias
    Prokharau, Aliaksandr
    Ghidini, Michele
    Faustino, Catia
    Gorbunova, Vera
    Zhavrid, Edvard
    Nishikawa, Kazuhiro
    Ando, Takayuki
    Yalcin, Suayib
    Van Cutsem, Eric
    Sabater, Javier
    Skanji, Donia
    Leger, Catherine
    Amellal, Nadia
    Ilson, David H.
    GASTRIC CANCER, 2020, 23 (04) : 689 - 698
12345